Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Early hair loss may indicate risk of insulin resistance.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

New treatments for male hypogonadism are effective and should be personalized.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Shen-Min, a hair growth supplement, likely caused acute hepatitis in a woman, improving after she stopped taking it.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.